Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity
- PMID: 2414919
- DOI: 10.1016/0042-6822(85)90303-4
Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity
Abstract
Measles virus monoclonal antibodies (MoAbs) were used to investigate the structure of the hemagglutinin (H) antigen, in order to study the regions of the molecule implicated in protection. Using a competition binding assay, three overlapping domains were defined, and these have been correlated with the biological activities of their corresponding MoAb. All of the anti-H MoAbs, with a single exception, neutralized virus infectivity in vitro. We investigated their capacity in passive protection using a measles virus-mouse model, in which inoculated newborn mice died of an acute encephalitis. The course of the disease was monitored after passive administration of the MoAbs, and from their activity, these MoAbs could be divided in three groups: I--protective, II--inducer of a retarded disease, III--nonprotective. The isotype of the antibody did not play a direct role in determining the course of the disease. Moreover, we were able to correlate protection with biological activity of the MoAbs. Only the MoAbs which inhibit hemagglutination activity (HI) protected against the acute disease. Measles MoAbs which neutralize canine distemper virus (CDV) in vitro failed to passively protect CDV-infected mice against disease. These results suggest an immune mechanism for in vivo protection different from that implicated in in vitro neutralization. Administration of one MoAb (55) led to a retarded neurological disease. Mice receiving lower quantities of other protective MoAbs did not display such disease. These results are discussed in relationship to immunization and protection.
Similar articles
-
Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.J Virol. 1987 Dec;61(12):3896-901. doi: 10.1128/JVI.61.12.3896-3901.1987. J Virol. 1987. PMID: 2960833 Free PMC article.
-
Characterization of epitopes on the measles virus hemagglutinin.Virology. 1986 Jul 15;152(1):58-65. doi: 10.1016/0042-6822(86)90371-5. Virology. 1986. PMID: 2424173
-
Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.J Gen Virol. 1996 Oct;77 ( Pt 10):2479-89. doi: 10.1099/0022-1317-77-10-2479. J Gen Virol. 1996. PMID: 8887481
-
Neutralizing B cell response in measles.Viral Immunol. 2002;15(3):451-71. doi: 10.1089/088282402760312331. Viral Immunol. 2002. PMID: 12479395 Review.
-
Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.Viruses. 2016 Aug 2;8(8):216. doi: 10.3390/v8080216. Viruses. 2016. PMID: 27490564 Free PMC article. Review.
Cited by
-
Identification of immunodominant neutralizing epitopes on the hemagglutinin protein of rinderpest virus.J Virol. 2002 Feb;76(4):1691-6. doi: 10.1128/jvi.76.4.1691-1696.2002. J Virol. 2002. PMID: 11799164 Free PMC article.
-
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.J Virol. 1993 Oct;67(10):6025-32. doi: 10.1128/JVI.67.10.6025-6032.1993. J Virol. 1993. PMID: 8371352 Free PMC article.
-
Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.J Virol. 1995 Mar;69(3):1420-8. doi: 10.1128/JVI.69.3.1420-1428.1995. J Virol. 1995. PMID: 7531779 Free PMC article.
-
Suppression of measles virus expression by noncytolytic antibody in an immortalized macrophage cell line.J Virol. 1995 Feb;69(2):734-40. doi: 10.1128/JVI.69.2.734-740.1995. J Virol. 1995. PMID: 7815537 Free PMC article.
-
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).J Virol. 1988 Dec;62(12):4594-604. doi: 10.1128/JVI.62.12.4594-4604.1988. J Virol. 1988. PMID: 2460637 Free PMC article.